UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

2015-02-27

Document Type

Presentation

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacoeconomics and Pharmaceutical Economics | Pharmacy Administration, Policy and Regulation

Abstract

This presentation provides an overview of the hepatitis C virus monitoring program implemented for state Medicaid to contain costs and to promote optimal member care. Key clinical and economic outcomes of the monitoring program are highlighted and formulary management strategies for novel hepatitis C virus agents identified.

Presented at the American Drug Utilization Review Society 2015 Conference.

Keywords

Hepatitis C medication management, Medicaid, pharmacy, clinical management, drug utilization review, prescriber outreach and education, prior authorization, Massachusetts

DOI of Published Version

10.13028/nfpq-b240

Journal/Book/Conference Title

American Drug Utilization Review Society 2015

Share

COinS